FEATURES AND HIGHLIGHTS

  • New Patient Fact Sheet: Bedwetting

    The clinical definition of bedwetting (nocturnal enuresis) is when a child over the age of five years wets the bed at night on a regular ...
  • Feature: Why Does Most Erectile Dysfunction Go Untreated?

    Erectile dysfunction affects 18 million men in the U.S., yet most patients receive little or no treatment. Why does only one-quarter of men with ED ...
  • New Product: MYRBETRIQ

    Indication(s): Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
  • New Product: XTANDI

    Indication(s): Treatment of metastatic castration-resistant prostate cancer in patients who have previously received docetaxel.

News

Pentec Health Recalls Nutritional Prescriptions

Pentec Health is recalling unused nutritional prescriptions for renal patients compounded on or before May 2, 2013.

Meds for Back Pain Tied to Higher Erectile Dysfunction Risk

Long-term use of painkillers for back pain is tied to an increased risk of erectile dysfunction.

New Drug Approved for Advanced Prostate Cancer

The FDA has approved Bayer's Xofigo for the treatment of advanced prostate cancer with bone metastases.

Health Effects of Further Lowering Sodium Unclear

Lowering sodium levels to moderate seems to result in improved health outcomes, but the evidence is insufficient to assess the benefits and harms of further lowering levels.

Pelvic Organ Prolapse Surgery Loses Effectiveness

In women with pelvic organ prolapse who undergo abdominal sacrocolpopexy, the failure rates increase with longer follow-up.